Score Overview
Explore the 2021 public Archive ranking →
Where Tekla Healthcare Investors has ranked, year by year
Showing 10 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- HQH
2008: 77.4% · 2021: 37.3% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-29 | $ 20.95 | — |
1 Year2025-09-29 | $ 15.93 | 31.48% |
5 Years2021-09-29 | $ 14.73 | 42.24% |
10 Years2016-09-29 | $ 8.86 | 136.55% |
20 Years2006-09-29 | $ 2.82 | 7x |
30 Years1996-09-27 | $ 1.05 | 19x |
All Time1988-01-05 | $ 0.26 | 79x |
| Period | Last Price2026-09-29 | 1 Year2025-09-29 | 5 Years2021-09-29 | 10 Years2016-09-29 | 20 Years2006-09-29 | 30 Years1996-09-27 | All Time1988-01-05 |
|---|---|---|---|---|---|---|---|
| Price | $ 20.95 | $ 15.93 | $ 14.73 | $ 8.86 | $ 2.82 | $ 1.05 | $ 0.26 |
| Return | — | 31.48% | 42.24% | 136.55% | 7x | 19x | 79x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| 2025 | $ 99M | $ 98M | $ 59.00 |
| 2024 | $ 10M | $ 184M | $ 56.00 |
| 2023 | $ 58M | $ 56M | $ 214.00 |
| 2022 | -$ 192M | -$ 194M | $ 792.00 |
| 2021 | $ 157M | $ 155M | $ 935.00 |
| 2020 | $ 242M | $ 241M | $ 2M |
| 2019 | -$ 143M | -$ 145M | $ 1M |
| 2018 | $ 70M | $ 69M | $ 927.00 |
| 2017 | $ 123M | $ 121M | $ 6M |
| 2016 | $ 4M | -$ 56M | $ 883.00 |
| 2015 | $ 4M | $ 96M | $ 209.55K |
| 2014 | $ 2M | $ 222M | $ 1.12K |
| 2013 | $ 1M | $ 200M | |
| 2012 | $ 5M | $ 157M | |
| 2011 | $ 1M | $ 32M | |
| 2010 | $ 3M | $ 19M | |
| 2009 | $ 720K | -$ 36M | |
| 2008 | $ 2M | -$ 23M | |
| 2007 | $ 2M | $ 75M | |
| 2006 | $ 3M | -$ 15M | |
| 2005 | $ 1M | $ 62M | $ 300K |
| 2004 | $ 690K | $ 13M | $ 200K |
| 2003 | $ 990K | $ 54M | $ 2M |
| 2002 | $ 1M | -$ 75M | |
| 2001 | $ 2M | -$ 140M | $ 600K |
| 2000 | $ 2M | $ 286M | $ 300K |
| 1998 | $ 640K | -$ 47M | $ 200K |
| 1997 | $ 680K | $ 33M | |
| 1996 | $ 250K | $ 29M | $ 300K |
Tekla Healthcare Investors fundamental performance
Between 2005 and 2025, revenue grew from $ 1M to $ 99M and net income grew from $ 62M to $ 98M. Revenue increased in 11 of those 20 years; net income in 10.
Across Tekla Healthcare Investors's full reported history, from 1996 to 2025, revenue grew from $ 250K to $ 99M and net income grew from $ 29M to $ 98M. Revenue increased in 54% of the years measured; net income in 54%.
Tekla Healthcare Investors currently holds a 20-year HDB Score of 4.1 out of 10. How the HDB Score is calculated.
Membership
Continue HQH’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
